Facility Set to Open in Late 2019 as part of Neighborhood Hospital on Agnew Road
HEMPFIELD TWP., PA – Allegheny Health Network (AHN) today announced plans to open a cancer center in Hempfield Township, Westmoreland County, as part of a neighborhood hospital complex the Network is building at the junction of Agnew Road and Route 30.
AHN Cancer Institute – Hempfield will be the fifth community cancer center AHN expects to open in 2019, joining others already being developed in Monroeville, Erie, Butler and Beaver County. All are part of AHN’s commitment to providing high quality cancer care in closer-to-home settings for patients throughout the greater Pittsburgh region.
“At AHN, we believe cancer patients and their families deserve one-stop access to comprehensive clinical and support services in locations that are most convenient to them,” said Cynthia Hundorfean, AHN’s President and Chief Executive Officer. “We are excited to bring a high level of cancer care to our patients who live in Westmoreland County, and to see our network of cancer treatment sites continue to grow across western Pennsylvania.”
As the U.S. population continues to grow older, the number of cancer diagnoses is rising. About 1.7 million new cancer cases - 81,000 in Pennsylvania alone - are expected to be diagnosed in 2018, a two percent hike from 2015, according to the American Cancer Society. In addition, the number of cancer survivors in the U.S. is expected to rise to from 15.5 million to 20.3 million in 2026.
“In Pennsylvania, about 80 percent of new cancer diagnoses happen outside Allegheny and Philadelphia counties,” said David Parda, MD, Chair, AHN Cancer Institute. “We are committed to addressing the increasing cancer care needs of the western Pennsylvania community in the most effective and affordable manner by investing in more services close to where our patients live and by closely integrating them with our affiliated academic and quaternary cancer programs at AGH, West Penn and Johns Hopkins.”
Designed to support a patient-centered care model, the 55,000 square foot cancer center will provide a wide array of services, including; comprehensive diagnostic imaging – such as MRI, ultrasound, CT Scan, X-Ray, DEXA – Bone Density Scans and mammography; radiation oncology; medical oncology and infusion therapy; an on-site pharmacy; nutritional counseling; social services; and access to cancer clinical trials. The center’s decor will incorporate natural light and soft colors to create a calming atmosphere for patients and their families, with quiet exam rooms and comfortable waiting areas.
Expected to employ approximately 50 health care professionals, the cancer center is the latest in a number of steps taken over the past year to expand access to AHN physicians and programs in Westmoreland County. Earlier in 2018, the AHN Outpatient Center – Westmoreland opened on Nature Park Road in Hempfield Township, offering access to a variety of medical and surgical specialists, as well as physical and occupational therapy and lab testing and imaging services.
AHN Hempfield-Neighborhood Hospital is one of four new, smaller format hospitals that the network is building across western Pennsylvania. The facilities will be fully licensed hospitals that are open 24/7 and offer an assortment of onsite clinical care, including an emergency department, 10-12 inpatient beds, diagnostic care and other complementary medical services.
The AHN Cancer Institute provides leading oncology expertise and programs at the network’s hospitals and affiliated clinics that serve patients from western Pennsylvania, Erie, West Virginia and Ohio.
AHN Cancer Institute – Hempfield is part of a nearly $300 million investment being made by Highmark Health and AHN to expand and enhance cancer care options in the western PA region. In addition to the five new community cancer centers, AHN is also building a new academic cancer center at Allegheny General Hospital and further strengthening its unique collaboration with the Johns Hopkins Kimmel Cancer Center, offering enhanced local access to Hopkins’ cancer expertise and clinical trials.